人民财讯12月30日电，企查查APP显示，近日，亚宝药业（600351）(广东横琴)有限公司成立，注册资 本1亿元，经营范围包括医学研究和试验发展、生物化工产品技术研发、生物基材料聚合技术研发等。 企查查股权穿透显示，该公司由亚宝药业、亚宝药业(澳门)有限公司共同持股。 ...

Group 1 - The establishment of Guotou Biological Manufacturing Innovation Research Institute (Wuxi) Co., Ltd. has been announced, with a registered capital of 30 million yuan [1] - The company's business scope includes research and development of bio-based materials technology, production process of biomass liquid fuels, bio-chemical products technology, and artificial intelligence theory and algorithm software development [1] - The company is jointly held by the wholly-owned subsidiary of China National Development Investment Corporation and Wuxi Life Science Industry Development Co., Ltd. [1]